Granulocyte colony-stimulating factor improves left ventricular function of doxorubicin-induced cardiomyopathy

This publication has 40 references indexed in Scilit:

• Thrombopoietin Protects Against In Vitro and In Vivo Cardiotoxicity Induced by Doxorubicin
  Circulation, 2006
• Granulocyte Colony-Stimulating Factor Reduces Cardiomyocyte Apoptosis and Improves Cardiac Function in Adriamycin-Induced Cardiomyopathy in Rats
  Cardiovascular Drugs and Therapy, 2006
• Concurrent Therapies That Protect Against Doxorubicin-Induced Cardiomyopathy
  Clinical Journal of Oncology Nursing, 2004
• Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity
  Pharmacological Reviews, 2004
• Cytokines are not upregulated in adriamycin-induced cardiomyopathy and heart failure
  Journal of Molecular and Cellular Cardiology, 2004
• Cyclooxygenase-2 Inhibitor Treatment Improves Left Ventricular Function and Mortality in a Murine Model of Doxorubicin-Induced Heart Failure
  Circulation, 2004
• Cytokine therapy prevents left ventricular remodeling and dysfunction after myocardial infarction through neovascularization
  The FASEB Journal, 2004
• Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist
  Blood, 2003
• Progression From Compensated Hypertrophy to Failure in the Pressure-Overloaded Human Heart
  Circulation, 2003
• Doxorubicin-induced Apoptosis in Spontaneously Hypertensive Rats: Differential Effects in Heart, Kidney and Intestine, and Inhibition by ICRF-187
  Journal of Molecular and Cellular Cardiology, 1996